Conjunctival microcysts density increases after canaloplasty

Article

Conjunctival microcysts density and surface area increases after canaloplasty in glaucomatous eyes.

Conjunctival microcysts density and surface area increases after canaloplasty in glaucomatous eyes, according to an investigation in the British Journal of Ophthalmology.

A team led by Dr Luca Agnifili, Department of Medicine and Ageing Science, Ophthalmic Clinic, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy, looked at 30 consecutive glaucomatous patients. Successful canaloplasty was completed if preoperative intraocular pressure (IOP) was reduced by a third.

Confocal laser-scanning microscopy was used to examine the conjunctiva one week before and 12 weeks after surgery. Outcome measures included the mean density and mean area of the conjunctival microcysts and IOP. Postoperative trabecular distension and scleral modifications were assessed using anterior segment optical coherence tomography.

Twelve weeks postoperatively, canaloplasty was successfully completed in 23 patients (Group 1) but unsuccessful in seven patients (Group 2). IOP was measured at 28.1+/-2.98 and 28.3+/-2.81 mm Hg for groups 1 and 2, respectively. Baseline IOP was 28.1+/-2.98 and 28.3+/-2.81 mm Hg, MMD was 10.61+/-4.31 and 11.35+/-5.6 and MMA was 2845.02+/-411.85 and 2700.56+/-518.85 in groups 1 and 2, respectively.

It was found that density and surface area of the conjunctival microcysts were increased. The aqueous humour filtration across the sclera and conjunctiva were enhanced after canaloplasty.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.